Clinical trials

Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.

2,386 studies match

clinicaltrialsPublishedShowing 301–350 of 2,386 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04933695	A Study of Sotorasib (AMG 510) in Participants With Stage IV NSCLC Whose Tumors Harbor a KRAS p.G12C Mutation in Need of First-line Treatment(CodeBreaK201)	terminated	Phase 2	42	AmgenINDUSTRY	10	Jul 13, 2026	clinicaltrials
NCT06307431	A Study of Adjuvant Intismeran Autogene (V940) and Pembrolizumab in Renal Cell Carcinoma (V940-004).(INTerpath-004)	active not recruiting	Phase 2	272	Merck Sharp & Dohme LLCINDUSTRY	14